Healio
Healio Minute
The latest health care news you need, when you need it. Only at Healio.
Be sure to visit the podcast's website and support the creator: www.healio.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Leukemia Edition: Top Headlines for Week of March 13, 2023 16.03.2023 14:59
In this edition, outpatient HSCT feasible for older adults; ponatinib for newly diagnosed Ph+ALL; iomab-B may increase transplant access in relapsed/refractory AML and more. Read the full coverage here: Outpatient HSCT feasible for older adults with AML, myelodysplastic syndrome Ponatinib 'should be considered a standard of care' for newly diagnosed Ph+ALL Iomab-B may increase transplant access, i...
Lung Cancer Edition: Top Headlines for Week of March 6, 2023 09.03.2023 10:44
In this edition, nivolumab confers durable survival benefit; global economic cost of cancer estimated to exceed $25 trillion; phase 3 trials of pembrolizumab miss primary endpoints, and more. Read the full coverage here: Neoadjuvant nivolumab confers durable survival benefit in resectable NSCLC Global economic cost of cancer estimated to exceed $25 trillion over 30 years Phase 3 trials of pembroli...
Leukemia Edition: Top Headlines for Week of February 13, 2023 16.02.2023 13:49
In this edition, novel T-cell therapy effective against common viruses; FDA approves Brukinsa for chronic lymphocytic leukemia; meeting abstracts show inconsistent toxicity reporting and more. Read the full coverage here: Novel T-cell therapy effective against common viruses after stem cell transplantation FDA approves Brukinsa for chronic lymphocytic leukemia, small lymphocytic lymphoma Review of...
Lung Cancer Edition: Top Headlines for Week of February 6, 2023 09.02.2023 11:10
In this edition, lobectomy alternatives show adverse event profiles; frequent CT scans not linked to better surgery outcomes; FDA approves adjuvant Keytruda, and more. Read the full coverage here: Lobectomy alternatives show varying adverse event profiles in early-stage lung cancer More frequent CT scans not linked to better outcomes after lung cancer surgery Osimertinib-related pneumonitis incide...
Lung Cancer Edition: Top Headlines for Week of January 9, 2023 12.01.2023 11:00
In this edition, addition of tumor treating fields extends OS; atezolizumab-bevacizumab survival rates; screening leads to more stage I, less stage IV disease incidence, and more. Read the full coverage here: Addition of tumor treating fields to standard therapy extends OS in advanced lung cancer Atezolizumab-bevacizumab confers 'much higher than usual' survival rates in NSCLC subset Lung cancer s...
Gastroenterology Edition: Top Headlines for Week of January 9, 2023 10.01.2023 11:39
In this edition, groups support CMS policy update on colonoscopy; plant-based food intake and CRC research needed; FDA agrees on pediatric study to develop obefazimod and more. Read the full coverage here: Exact Sciences backs CMS policy update to waive cost-sharing for follow-up colonoscopy Future research needed to investigate link between plant-based food intake, CRC FDA agrees on Abivax's pedi...
Hematology Oncology Edition: Healio's Top Headlines of 2023 29.12.2022 11:16
In this edition, NCI director announces breast cancer diagnosis, neoadjuvant chemotherapy regimen in pancreatic cancer, gender harassment is in oncology and more. Read the full coverage here: NCI director announces breast cancer diagnosis, says prognosis 'very favorable' Neoadjuvant chemotherapy regimen extends survival in pancreatic cancer Survey shows gender harassment is 'strikingly common' in...
Hematology Oncology Edition: Top Headlines for Week of December 19, 2022 22.12.2022 11:55
In this edition, cancer and COVID-19 increase risk for thromboembolism, glofitamab shows curative potential in lymphoma, efgartigimod improves platelet counts, and more. Read the full coverage here: Biomarkers predict thromboembolism risk, mortality among people with cancer, COVID-19 Glofitamab shows 'curative potential' in relapsed/refractory diffuse large B-cell lymphoma Efgartigimod confers rap...
Hematology Oncology Edition: Top Headlines for Week of December 12, 2022 15.12.2022 13:48
In this edition, alcohol consumption increases cancer risk, medical marijuana associated with lower rates of opioid prescriptions, lifelong stress increases risk for cancer mortality, and more. Read the full coverage here: Many Americans unaware of alcohol links to cancer risk Medical marijuana 'may be substituting for opioids for cancer-related pain' Lifelong stress may increase risk for cancer m...
Breast Cancer Edition: Top Headlines for Week of December 12, 2022 13.12.2022 10:19
In this episode, FDA grants fast track designation to REM-001; practice-changing treatment advances continue; proton partial breast radiotherapy appears effective and more. Read the full coverage here: FDA grants fast track designation to REM-001 for cutaneous metastatic breast cancer Practice-changing treatment advances continue in early-stage triple-negative breast cancer Proton partial breast r...
Hematology Onocology Edition: Top Headlines for Week of December 5, 2022 08.12.2022 9:59
In this edition, fludarabine has been placed on the FDA's drug shortage list; epcoritamab is approved for advanced lymphoma; pembrolizumab with chemotherapy improves OS in gastric cancer, and more. Read the full coverage here: Fludarabine shortage requires flexibility, alternative approaches for CAR-T and HSCT FDA grants priority review to epcoritamab for advanced lymphoma Pembrolizumab regimen ex...
Neurology Edition: Top Headlines for Week of December 5, 2022 08.12.2022 12:43
In this edition, foslevodopa-foscarbidopa improves motor symptoms in advanced PD, posterior surgery for treating cervical radiculopathy, Tysabri favored over IV in patients with relapsing-remitting MS and more. Read the full coverage here: Continuous subcutaneous foslevodopa-foscarbidopa improves motor symptoms in advanced PD Posterior surgery noninferior to anterior for treating cervical radiculo...
Neurology Edition: Top Headlines for Week of November 28, 2022 01.12.2022 11:43
In this edition, risk factors linked to PD, digital brain health platform offers dementia risk assessment, Klotho protein levels linked to Alzheimer's and more. Read the full coverage here: Tremor, restless legs syndrome, schizophrenia among risk factors linked to PD Digital brain health platform offers rapid, accurate assessment of dementia risk Klotho protein levels linked to Alzheimer's, cognit...
Hematology Oncology Edition: Top Headlines for Week of November 28, 2022 30.11.2022 13:13
In this edition, disparities among women in the surgical workforce, GSK withdraws belantamab mafodotin from US market, risk for lymphoma low after postmastectomy reconstruction, and more. Read the full coverage here: More women surgeon scientists receive NIH funding than in 2010, yet gender gaps remain GSK to withdraw multiple myeloma therapy from US market Risk for lymphoma after postmastectomy b...
Hematology Oncology Edition: Top Headlines for Week of November 21, 2022 24.11.2022 11:21
In this edition, lung cancer screening critically low across the U.S, first in-human CRISPR test with gene replacement, racial and economic segregation linked to higher cancer mortality rates, and more. Read the full coverage here: Lung cancer screening rates in US 'simply unacceptable' First CRISPR-based cell therapy to use gene replacement feasible, safe for solid tumors Racial, economic segrega...
Gastroenterology Edition: Top Headlines for Week of November 21, 2022 23.11.2022 12:42
In this edition, best practice statements for celiac disease; older patients with IBD at risk for treatment failure with vedolizumab; Follow-up surveillance for post-colonoscopy CRC and more. Read the full coverage here: AGA releases 10 best practice statements for management of refractory celiac disease Older patients with IBD at higher risk for treatment failure with vedolizumab Follow-up survei...
Hematology Oncology Edition: Top Headlines for Week of November 14, 2022 17.11.2022 13:13
In this edition, the importance of vaccination after cell therapy, artificial intelligence may help predict cardiotoxicity, experimental breast cancer vaccine generates immune response, and more. Read the full coverage here: Revaccination guidance after cell therapy established for some, 'evolving' for others Artificial intelligence may help predict cardiotoxicity in renal cell carcinoma Experimen...
Neurology Edition: Top Headlines for Week of November 14, 2022 17.11.2022 8:27
In this edition, neurologic effects of COVID-19 among pediatric populations, FDA accepts NDA for extended-release carbidopa/levodopa, antihistamines could be promising therapy for Parkinson's disease and more. Read the full coverage here: Neurologic effects of COVID-19 persisted among pediatric populations in 2021 FDA accepts NDA for extended-release carbidopa/levodopa Parkinson's treatment Antihi...
Breast Cancer Edition: Top Headlines for Week of November 7, 2022 11.11.2022 13:07
In this episode, data show 'critical need' for universal genetic testing; patients with inflammatory breast cancer at high risk for brain metastases; palbociclib fails to benefit breast cancer subgroup and more. Read the full coverage here: Data show 'critical need' for universal genetic testing of patients with breast cancer Patients with inflammatory breast cancer at high risk for brain metastas...
Hematology Oncology Edition: Top Headlines for Week of November 7, 2022 10.11.2022 13:35
In this edition, FDA approves Tecvayli for multiple myeloma, radiation and hormone therapy slows progression of prostate cancer, and more. Read the full coverage here: FDA approves Tecvayli for advanced multiple myeloma Adding radiation to hormone therapy slows progression of oligometastatic prostate cancer Use of cannabis during cancer treatment may have 'under-appreciated' financial impact Older...
Neurology Edition: Top Headlines for Week of November 7, 2022 10.11.2022 11:32
In this edition, we bring you more news and Healio-exclusive interviews from the American Neurological Association Annual Meeting. Read the full coverage here: Diversity key to understanding genetics of neurodegenerative disease Assessing chemical exposures key to understanding neuro diseases and disorders VIDEO: Neurological complications can spur from certain infectious diseases Age, specific pa...
Gastroenterology Edition: Top Headlines for Week of November 7, 2022 09.11.2022 10:46
In this edition, Achalasia is associated with higher esophageal cancer risk; FDA rejects bulevirtide for hepatitis D and liver disease; real-world data on colonoscopy prep and more. Read the full coverage here: Achalasia associated with five-fold higher risk for esophageal cancer FDA rejects Gilead's bulevirtide for hepatitis D, compensated liver disease Polyethylene glycol, ascorbic acid cleanse...
Neurology Edition: Top Headlines for Week of October 31, 2022 03.11.2022 15:07
In this edition, we bring you news and Healio-exclusive interviews from the American Neurological Association Annual Meeting. Read the full coverage here: Optimism in older adults improves functional recovery after stroke Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis VIDEO: Functional movement disorders diagnosed on presence of positive criteria Pain, sleep, mo...
Neurology Edition: Top Headlines for Week of October 24, 2022 27.10.2022 11:09
In this edition, COVID-19 patients at risk for post-infection complications; VR for patients with back pain; FDA requests further analysis of Supernus Parkinson's treatment and more. Read the full coverage here: Evaluate headache characteristics to classify as migraine FDA grants breakthrough device designation for brain implant technology New genetic engineering company aims to develop neuroactiv...
Gastroenterology Edition: Top Headlines for Week of October 24, 2022 26.10.2022 13:41
In this edition, AGA speaks out on controversial NordICC data; first US patient enrolled in phase 3 trial of obefazimod; 'unprecedented' shift in hepatitis A outbreaks and more. Read the full coverage here: AGA speaks out on controversial NordICC data citing modest colonoscopy benefit for CRC First US patient enrolled in Abivax's phase 3 trial of obefazimod for ulcerative colitis Shift in hepatiti...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.